Augmentation of Behavior Therapy With d -Cycloserine for Obsessive-Compulsive Disorder
Authors:
- Sabine WilhelmSWSabine Wilhelm
- Ulrike BuhlmannUBUlrike Buhlmann
- David F. TolinDTDavid F. Tolin
- Suzanne A. MeunierSMSuzanne A. Meunier
- Godfrey D. PearlsonGPGodfrey D. Pearlson
- Hannah E. ReeseHRHannah E. Reese
- Paul CannistraroPCPaul Cannistraro
- Michael A. JenikeMJMichael A. Jenike
- Scott L. RauchSRScott L. Rauch
- 1 March 2008
- journal article
- research article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 165 (3) , 335-341
Abstract
Objective: This study examined whether d -cycloserine, a partial agonist at the N -methyl- d -aspartate (NMDA) glutamatergic receptor, enhances the efficacy of behavior therapy for obsessive-compulsive disorder (OCD). Method: A randomized, double-blind, placebo-controlled trial investigating d -cycloserine versus placebo augmentation of behavior therapy was conducted in 23 OCD patients. Patients first underwent a diagnostic interview and pretreatment evaluation, followed by a psychoeducational/treatment planning session. Then they received 10 behavior therapy sessions. Treatment sessions were conducted twice per week. One hour before each of the behavior therapy sessions, the participants received either d -cycloserine, 100 mg, or a placebo. Results: Relative to the placebo group, the d -cycloserine group’s OCD symptoms were significantly more improved at mid-treatment, and the d -cycloserine group’s depressive symptoms were significantly more improved at posttreatment. Conclusions: These data provide support for the use of d -cycloserine as an augmentation of behavior therapy for OCD and extend findings in animals and other human disorders suggesting that behavior therapy acts by way of long-term potentiation of glutamatergic pathways and that the effects of behavior therapy are potentiated by an NMDA agonist.Keywords
This publication has 26 references indexed in Scilit:
- D-Cycloserine Augmented Exposure Therapy for Obsessive-Compulsive DisorderBiological Psychiatry, 2007
- Augmentation of Exposure Therapy With D-Cycloserine for Social Anxiety DisorderArchives of General Psychiatry, 2006
- Treatment of obsessive–compulsive disorder: Cognitive behavior therapy vs. exposure and response preventionBehaviour Research and Therapy, 2005
- Cognitive Enhancers as Adjuncts to PsychotherapyArchives of General Psychiatry, 2004
- A six-month, placebo-controlled trial of d-cycloserine co-administered with conventional antipsychotics in schizophrenia patientsPsychopharmacology, 2004
- Post-treatment effects of exposure therapy and clomipramine in obsessive-compulsive disorderDepression and Anxiety, 2004
- Long‐term potentiation as a substrate for memory: Evidence from studies of amygdaloid plasticity and Pavlovian fear conditioningHippocampus, 2002
- Acute but not chronic activation of the NMDA-coupled glycine receptor with D-cycloserine facilitates learning and retentionEuropean Journal of Pharmacology, 1994
- Desensitization of the NMDA receptor complex by glycinergic ligands in cerebellar granule cell culturesBrain Research, 1993
- The Yale-Brown Obsessive Compulsive ScaleArchives of General Psychiatry, 1989